{"id":"W2549844032","doi":"10.1016/s0140-6736(16)31651-8","title":"Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study","year":2016,"lang":"en","type":"article","venue":"The Lancet","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"UCB Pharma","keywords":"Medicine; Certolizumab pegol; Rheumatoid arthritis; Adalimumab; Internal medicine; Methotrexate; Rheumatoid factor; Rheumatology; Erythrocyte sedimentation rate; TNF inhibitor; Physical therapy; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004113843,0.002640497,0.00662124,0.00054649,0.0003744103,0.001745484,0.001408903,0.001870431,0.006520092],"category_scores_gemma":[0.003513536,0.001095947,0.005694405,0.0006286249,0.001552168,0.001700189,0.0008347005,0.003770114,0.001499316],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001060002,"about_ca_system_score_gemma":0.0007355634,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001715122,"about_ca_topic_score_gemma":0.002474016,"domain_scores_codex":[0.9974431,0.001478682,0.0001860613,0.0003725955,0.0001767325,0.0003428221],"domain_scores_gemma":[0.997505,0.001135819,0.000620859,0.0002934554,0.0001263717,0.0003184718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9859277,0.0005673094,0.0005019166,0.00052445,0.00425979,0.00002842766,0.00002603812,0.000205849,0.0005455261,0.00004326853,0.0002952015,0.00707444],"study_design_scores_gemma":[0.9397362,0.04436314,0.00638959,0.00009055212,0.007551553,0.00005966363,0.00005700668,0.0003317959,0.0004888623,0.000273819,0.0006188928,0.00003896329],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9624699,0.02967221,0.0007154893,0.0008623439,0.001069282,0.0005499437,0.001751484,0.0001275841,0.002781715],"genre_scores_gemma":[0.9875672,0.006538547,0.0004826174,0.0009398673,0.0007888848,0.0002878687,0.0009500913,0.00004755737,0.002397398],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00662124,"threshold_uncertainty_score":0.0218119,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05612515584179657,"score_gpt":0.3451581575825471,"score_spread":0.2890330017407505,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}